The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation
Open accessAbstract
It has been proposed that the cell-mediated activation of progelatinase A requires binding of the C-terminal domain of the proenzyme to a membrane-associated complex of the membrane type matrix metalloproteinase MT1-MMP and TIMP-2. Subsequent sequential proteolysis of the propeptide by MT1-MMP and gelatinase A is thought to generate the active form of gelatinase A. We have prepared the proform of the catalytic domain of the MT1-MMP and demonstrated that this may be activated in vitro by trypsin proteolysis to yield a functional proteinase capable of cleaving typical metalloproteinase peptide substrates, gelatin and casein. The active catalytic domain of MT1-MMP was also shown to activate progelatinase A to a fully active form. Using the inactive mutant pro-E375A gelatinase A, we dissected the propeptide processing events that occur. MT1-MMP cleaves the propeptide at the sequence Asn37-Leu38 only. Further cleavage of the mutant enzyme propeptide at Asn80-Tyr81, equivalent to that of the active wild type gelatinase A, could only be effected by addition of gelatinase A to the system. TIMP-1 was essentially unable to prevent MT1-MMP processing of wild type or E375A progelatinase A, whereas TIMP-2 and TIMP-3 were good inhibitors of these events. Analysis of the rate of binding of TIMPs to the catalytic domain of MT1-MMP using kinetic methods showed that TIMP-1 is an extremely poor inhibitor of MT1-MMP. In comparison, TIMP-2 and TIMP-3 are excellent inhibitors, binding more rapidly to the catalytic domain of MT1-MMP than to the catalytic domain of gelatinase A. These data demonstrate the basic mechanism of MT1-MMP action on progelatinase A and the reason for the lack of inhibition by TIMP-1 previously demonstrated in cell-based activation studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,551
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis
Stetler-Stevenson, W. G., Aznavoorian, S., & Liotta, L. A. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.002545 · Cited by 1,526
Biochemical Characterization of Human Collagenase-3
Knäuper, V., López-Otin, C., Smith, B., Knight, G., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1544 · Cited by 881
Self-citationCellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation
Knäuper, V., Will, H., López-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17124 · Cited by 747
Self-citationA novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases
Knight, C. G., Willenbrock, F., & Murphy, G. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80300-6 · Cited by 702
Self-citationOKADA, Y., MORODOMI, T., ENGHILD, J. J., SUZUKI, K., YASUI, A., NAKANISHI, I., SALVESEN, G., & NAGASE, H. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19462.x · Cited by 429
Strongin, A. Y., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85205-5 · Cited by 336
Will, H., & Hinzmann, B. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0602d.x · Cited by 336
Self-citationMurphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O'Shea, M., & Docherty, A. J. P. (1991) · Biochemistry · doi:10.1021/bi00247a001 · Cited by 324
Self-citation
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Matrix Metalloproteinases: Role In Arthritis
Burrage, P. (2006) · Frontiers in Bioscience · doi:10.2741/1817 · Cited by 1,292
Wolf, K., Wu, Y. I., Liu, Y., Geiger, J., Tam, E., Overall, C., Stack, M. S., & Friedl, P. (2007) · Nature Cell Biology · doi:10.1038/ncb1616 · Cited by 1,010
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.221 · Cited by 943
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
Raffetto, J. D., & Khalil, R. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.004 · Cited by 752
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-R¨th, F.-X., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G. P., et al. (1997) · Nature · doi:10.1038/37995 · Cited by 619
Matrix metal loproteinases and the development of cancer
Coussens, L. M., & Werb, Z. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90178-7 · Cited by 568
Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement
Ullah, M., Liu, D. D., & Thakor, A. S. (2019) · iScience · doi:10.1016/j.isci.2019.05.004 · Cited by 549
Ries, C., Egea, V., Karow, M., Kolb, H., Jochum, M., & Neth, P. (2007) · Blood · doi:10.1182/blood-2006-10-051060 · Cited by 539
Receptor‐mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD)
Okada, Y., Maeno, E., Shimizu, T., Dezaki, K., Wang, J., & Morishima, S. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0003g.x · Cited by 530
Hemmann, S., Graf, J., Roderfeld, M., & Roeb, E. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.003 · Cited by 509
Overall, C. M. (2002) · Molecular Biotechnology · doi:10.1385/mb:22:1:051 · Cited by 504
Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression
Niland, S., Riscanevo, A. X., & Eble, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010146 · Cited by 503
MT1‐MMP: A potent modifier of pericellular microenvironment
Itoh, Y., & Seiki, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20431 · Cited by 499
Butler, G. S., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., van Westrum, S. S., Crabbe, T., Clements, J., d'Ortho, M.-P., & Murphy, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.871 · Cited by 470
Self-citationBaker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Matrix metalloproteinases in inflammation
Nissinen, L., & Kähäri, V.-M. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.03.007 · Cited by 444
D'ortho, M., Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L., & Murphy, G. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00751.x · Cited by 443
Self-citationMechanisms for pro matrix metalloproteinase activation
MURPHY, G., STANTON, H., COWELL, S., BUTLER, G., KNÄUPER, V., ATKINSON, S., & GAVRILOVIC, J. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01524.x · Cited by 441
Self-citationMembrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion
Seiki, M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00699-7 · Cited by 406
Membrane-type matrix metalloproteinases: Their functions and regulations
Itoh, Y. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.03.004 · Cited by 401
Itoh, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4782 · Cited by 399
TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo
Wang, Z., Juttermann, R., & Soloway, P. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001270200 · Cited by 390
Deryugina, E. I., Ratnikov, B., Monosov, E., Postnova, T. I., DiScipio, R., Smith, J. W., & Strongin, A. Y. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5118 · Cited by 387
Fitzgerald, M. L., Wang, Z., Park, P. W., Murphy, G., & Bernfield, M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.811 · Cited by 367
Self-citationTsukada, S., Parsons, C. J., & Rippe, R. A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.014 · Cited by 357
Shamamian, P., Schwartz, J. D., Pocock, B. J. Z., Monea, S., Whiting, D., Marcus, S. G., & Mignatti, P. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10014 · Cited by 353
Haas, T. L., Davis, S. J., & Madri, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3604 · Cited by 351
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia
Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A., & de Bont, E. S. J. M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.001 · Cited by 350
Knäuper, V., Cowell, S., Smith, B., López-Otin, C., O'Shea, M., Morris, H., Zardi, L., & Murphy, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7608 · Cited by 350
Self-citationMatrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer
Kerkelä, E., & Saarialho‐Kere, U. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.120201.x · Cited by 345
Structural properties of matrix metalloproteinases
Bode, W., Fernandez-Catalan, C., Grams, H. T., & Maskos, H. N. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050320 · Cited by 329
Regulation of Membrane Type-1 Matrix Metalloproteinase Activation by Proprotein Convertases
Yana, I., & Weiss, S. J. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.7.2387 · Cited by 322
Fernandez‐Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J. J., Lichte, A., Tschesche, H., & Maskos, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5238 · Cited by 321
Hernandez-Barrantes, S., Toth, M., Bernardo, M. M., Yurkova, M., Gervasi, D. C., Raz, Y., Sang, Q. A., & Fridman, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12080 · Cited by 313
Metalloproteinases and their inhibitors in tumor angiogenesis
Handsley, M. M., & Edwards, D. R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20945 · Cited by 307
Relating matrix metalloproteinase structure to function: Why the “hemopexin” domain?
Murphy, G., & Knäuper, V. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90025-1 · Cited by 306
Self-citationWiseman, B. S., Sternlicht, M. D., Lund, L. R., Alexander, C. M., Mott, J., Bissell, M. J., Soloway, P., Itohara, S., & Werb, Z. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302090 · Cited by 303
Human endothelial gelatinases and angiogenesis
Nguyen, M. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00007-3 · Cited by 300
Membrane‐type matrix metalloproteinases
SEIKI, M. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01536.x · Cited by 300
Olson, M. W., Gervasi, D. C., Mobashery, S., & Fridman, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29975 · Cited by 288
Shek, F. W.-T., Benyon, R. C., Walker, F. M., McCrudden, P. R., Pender, S. L. F., Williams, E. J., Johnson, P. A., Johnson, C. D., Bateman, A. C., Fine, D. R., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61125-x · Cited by 288
Kinoshita, T., Sato, H., Okada, A., Ohuchi, E., Imai, K., Okada, Y., & Seiki, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16098 · Cited by 281
Zucker, S., Drews, M., Conner, C., Foda, H. D., DeClerck, Y. A., Langley, K. E., Bahou, W. F., Docherty, A. J. P., & Cao, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.1216 · Cited by 281
MT1‐MMP proinvasive activity is regulated by a novel Rab8‐dependent exocytic pathway
Bravo‐Cordero, J. J., Marrero‐Diaz, R., Megías, D., Genís, L., García‐Grande, A., García, M. A., Arroyo, A. G., & Montoya, M. C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601606 · Cited by 269
Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis
Jiang, A., Lehti, K., Wang, X., Weiss, S. J., Keski-Oja, J., & Pei, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241293698 · Cited by 267
Yoshiji, H., Kuriyama, S., Miyamoto, Y., Thorgeirsson, U. P., Gomez, D. E., Kawata, M., Yoshii, J., Ikenaka, Y., Noguchi, R., Tsujinoue, H., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.20521 · Cited by 252
Alvites, R., Branquinho, M., Sousa, A. C., Lopes, B., Sousa, P., & Maurício, A. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020381 · Cited by 174
Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
Lehti, K., Valtanen, H., Wickström, S., Lohi, J., & Keski-Oja, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910220199 · Cited by 144
Rozanov, D. V., Hahn-Dantona, E., Strickland, D. K., & Strongin, A. Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311569200 · Cited by 130
Individual Timp Deficiencies Differentially Impact Pro-MMP-2 Activation
English, J. L., Kassiri, Z., Koskivirta, I., Atkinson, S. J., Di Grappa, M., Soloway, P. D., Nagase, H., Vuorio, E., Murphy, G., & Khokha, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512009200 · Cited by 120
Self-citationComplex Pattern of Membrane Type 1 Matrix Metalloproteinase Shedding
Toth, M., Hernandez-Barrantes, S., Osenkowski, P., Bernardo, M. M., Gervasi, D. C., Shimura, Y., Meroueh, O., Kotra, L. P., Gálvez, B. G., Arroyo, A. G., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200655200 · Cited by 119
TACE/ADAM‐17 maturation and activation of sheddase activity require proprotein convertase activity
Srour, N., Lebel, A., McMahon, S., Fournier, I., Fugère, M., Day, R., & Dubois, C. M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01159-1 · Cited by 103
Zhai, Y., Hotary, K. B., Nan, B., Bosch, F. X., Muñoz, N., Weiss, S. J., & Cho, K. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0231 · Cited by 97
MMP14 in sarcoma: a regulator of tumor microenvironment communication in connective tissues
Gonzalez-Molina, J., Gramolelli, S., Liao, Z., Carlson, J. W., Ojala, P. M., & Lehti, K. (2019) · Cells · doi:10.3390/cells8090991 · Cited by 89
Characterization of the Role of the “MT-loop”
English, W. R., Holtz, B., Vogt, G., Knäuper, V., & Murphy, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107783200 · Cited by 69
Self-citationGrossman, M., Tworowski, D., Dym, O., Lee, M.-H., Levy, Y., Murphy, G., & Sagi, I. (2010) · Biochemistry · doi:10.1021/bi902141x · Cited by 68
Self-citationRozanov, D. V., Deryugina, E. I., Monosov, E. Z., Marchenko, N. D., & Strongin, A. Y. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.10.006 · Cited by 64
Higashi, S., & Miyazaki, K. (2003) · Biochemistry · doi:10.1021/bi020643m · Cited by 53
Nakamichi, Y., Udagawa, N., Kobayashi, Y., Nakamura, M., Yamamoto, Y., Yamashita, T., Mizoguchi, T., Sato, M., Mogi, M., Penninger, J. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.192 · Cited by 50
Lang, R., Braun, M., Sounni, N. E., Noel, A., Frankenne, F., Foidart, J.-M., Bode, W., & Maskos, K. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.022 · Cited by 42
Paumier, J.-M., Py, N. A., García-González, L., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., & Rivera, S. (2019) · The FASEB Journal · doi:10.1096/fj.201801076r · Cited by 40
Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets
Itaba, N., Kono, Y., Watanabe, K., Yokobata, T., Oka, H., Osaki, M., Kakuta, H., Morimoto, M., & Shiota, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-43298-0 · Cited by 29
Metadata
- Authors
- Will, H., Atkinson, S. J., Butler, G. S., Smith, B., & Murphy, G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-07
- Volume
- 271
- Issue
- 29
- Pages
- 17119-17123
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2068843202
- Cited by
- 569
- References
- 26
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.